DeepTech深科技|这款阿尔茨海默症口服药“涅槃重生”,获得NIH资助以开展III期临床( 二 )


参考:
https://xconomy.com/boston/2020/08/20/alzheon-lands-47m-to-take-another-shot-at-a-pivotal-alzheimers-test/
https://www.fiercebiotech.com/biotech/no-ipo-no-problem-alzheon-bags-47m-nih-grant-to-bankroll-alzheimer-s-trial
-End-
DeepTech深科技|这款阿尔茨海默症口服药“涅槃重生”,获得NIH资助以开展III期临床
本文插图

DeepTech深科技|这款阿尔茨海默症口服药“涅槃重生”,获得NIH资助以开展III期临床
本文插图
【DeepTech深科技|这款阿尔茨海默症口服药“涅槃重生”,获得NIH资助以开展III期临床】


推荐阅读